Biologic Excipients Market Overview
An overview of conceptual frameworks, analytical approaches of the biologic excipients market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The biologic excipients market is expected to grow at a significant rate in the near future.
The global biologic excipients market in 2020 is estimated for more than US$ 1,245.3 Mn and expected to reach a value of US$ 1,630.6 Mn by 2028 with a significant CAGR of 3.4%.
Biologic Excipients Market Dynamics
Increase in focus of market players on the bio-generic market, cost-effectiveness factor along with intense competition among the manufacturers, issues linked with the patents like the expiry of biological actives, and the mounting adoption of multi-purpose nature and functionality excipients are the prime factors supporting the market growth globally. Besides, the on-going research studies with the technological advancements to enhance the capability of the end product of bioavailability using excipients coupled with the growing demand for generic medicines from developing countries propelling the production of local drugs and the uptake of biologics resulting in driving demand for parenteral formulation are also expected to boost the biologic excipients market during the forecast period. Rising acquisition of contract research organizations, penetrating demand for the oral solid-liquid formulation, emerging adoption of technologies for advanced drug delivery systems, and the ability of biologic excipients to enhance solubility and bioavailability are other concerning factors fuelling the market growth.
Growing demand for generic drugs also positively impacts the market growth. For instance, the majority of the Indian population depends on generic drugs as they are available at low prices and have resulted in maximum efficacy in treating chronic diseases, thereby, boosting the demand for biologic excipients. However, the factors like the dearth of proper data documentation on GRAS, regulatory audits hampering the supply capacity, and the regulatory hurdles deterring the innovation of novel excipient restricts the market growth. On the contrary, the unstable focus of pharmaceutical manufacturing in emerging regions, like the Asia Pacific and the Middle East serves to offer lucrative growth opportunities for the market.
Biologic Excipients Market Segmentation
The biologic excipients market is segmented on the basis of excipient type, end-user, and by region.
By Excipient Type:
Polymers
Sugar Alcohols
Polysorbates
Inorganic Salts
Amino Acids
Surfactants
Others
By End-user:
Biopharmaceutical Manufacturers
Contract Research Organizations/Contract Manufacturing Organizations
Research Organizations
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Regional Segmentation
On the basis of region, the biologic excipients market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
